BriaCell Therapeutics Corp. (BCT.TO)
CAD 0.87
(-4.4%)
CAD 0.87
(-4.4%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 20.49 Thousand | 19.38 Thousand | 19.44 Thousand | 18.74 Thousand | 18.74 Thousand | 16.89 Thousand |
| Gross Profit | -20.49 Thousand | -19.38 Thousand | -19.44 Thousand | -18.74 Thousand | -18.74 Thousand | -16.89 Thousand |
| Operating Expenses | 23.27 Million | -3388.00 | -3.68 Million | -1.38 Million | -946.42 Thousand | -1.06 Million |
| Selling, General and Administrative Expenses | 7.93 Million | 7.26 Million | -3.67 Million | -1.37 Million | -932.16 Thousand | -1.05 Million |
| Research and Development Expenses | 15.33 Million | 8.02 Million | 1.31 Million | 2.22 Million | 3.73 Million | 2.38 Million |
| Other Expenses | - | -15.29 Million | -1.33 Million | -2.23 Million | -3.75 Million | -312.91 Thousand |
| Cost and Expenses | 23.27 Million | -3388.00 | -3.68 Million | -1.38 Million | -946.42 Thousand | -1.06 Million |
| Operating Income | -23.27 Million | -15.28 Million | 3.68 Million | 1.38 Million | 946.42 Thousand | -3.81 Million |
| Interest Expense | - | 979.00 | 46.09 Thousand | 26.99 Thousand | 23.81 Thousand | 15.62 Thousand |
| Income Tax Expense | -152.62 Thousand | 30.73 Thousand | 6.58 Million | -72.25 Thousand | 343.74 Thousand | -319.12 Thousand |
| Earnings before Tax | -20.3 Million | -11.54 Million | 3.68 Million | 1.38 Million | 946.42 Thousand | 1.06 Million |
| Net Income | -20.3 Million | -11.58 Million | -2.89 Million | 1.38 Million | 602.68 Thousand | 1.06 Million |
| Earnings Per Share Basic | -1.74 | -0.75 | -0.19 | 1.94 | 1.04 | 2.49 |
| Earnings Per Share Diluted | -1.74 | -0.75 | -0.19 | 1.94 | 1.04 | 2.49 |
| Weighted Average Shares Outstanding | 15.61 Million | 15.49 Million | 15.26 Million | 713.88 Thousand | 579.66 Thousand | 427.81 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 15.61 Million | 15.51 Million | 15.26 Million | 713.88 Thousand | 579.66 Thousand | 427.81 Thousand |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -27.22 Million | -34.04 Million | -17.48 Million | -4.88 Million | -5.73 Million | -5.37 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | 5179.72 | 5163.45 | 5183.81 | 5095.09 | 20.49 Thousand |
| Gross Profit | - | -5179.72 | -5163.45 | -5183.81 | -5095.09 | -20.49 Thousand |
| Operating Expenses | 5.76 Million | 9.22 Million | 9.82 Million | 8.5 Million | 7.7 Million | 23.27 Million |
| Selling, General and Administrative Expenses | 1.36 Million | 1.57 Million | 1.57 Million | 1.64 Million | 2.53 Million | - |
| Research and Development Expenses | 4.4 Million | 7.65 Million | 8.25 Million | 6.85 Million | 5.16 Million | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 5.76 Million | 9.22 Million | 9.82 Million | 8.5 Million | 7.7 Million | 23.27 Million |
| Operating Income | -5.76 Million | -9.22 Million | -9.82 Million | -8.5 Million | -7.7 Million | -23.27 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -34.58 Thousand | -10.98 Million | 1.44 Million | -14.5 Million | -39.99 Thousand | -152.62 Thousand |
| Earnings before Tax | -1.24 Million | 1.69 Million | -11.33 Million | 5.95 Million | -2.41 Million | -20.3 Million |
| Net Income | -1.21 Million | 1.71 Million | -11.29 Million | 6 Million | -2.41 Million | -20.3 Million |
| Earnings Per Share Basic | -0.07 | 0.11 | -0.71 | 0.38 | -154.27 | - |
| Earnings Per Share Diluted | -0.07 | 0.11 | -0.71 | -0.50 | -151.89 | - |
| Weighted Average Shares Outstanding | 18.02 Million | 15.98 Million | 15.98 Million | 15.98 Million | 15.67 Thousand | 15.61 Million |
| Weighted Average Shares Outstanding (Diluted) | 18.02 Million | 15.98 Million | 15.98 Million | 16.67 Million | 15.92 Thousand | 15.61 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -5.69 Million | -20.16 Million | -8.25 Million | -22.77 Million | -7.49 Million | - |
| Earnings Before Tax Margin | - | - | - | - | - | - |
GOSS
7578
4770
ASIMAR
ITX
0L8F